Steve, short answer: **the idea is already there technically, but the framing you wrote is *not* explicit in the paper — and adding a compact version would materially improve clarity and positioning.**

Longer, concrete answer below, grounded in your actual manuscript. 

---

## 1. Is this idea already in the paper?

### Technically: **yes**

### Conceptually / rhetorically: **no**

Everything you’re saying *exists* in the manuscript, but it’s **distributed across multiple sections** and expressed in formal survival-analysis language rather than as a clean epistemic contrast.

Specifically:

* You **do** already say:

  * Matching on living covariates fails under latent frailty (Intro §1.2, §1.4).
  * Cox fits a model to *conditional-on-survival* hazards (Methods §2.11).
  * KCOR works in cumulative-hazard space, operates on aggregates, and uses data directly after normalization (Box 1, §2.6–2.8).
  * RCTs are the gold standard but infeasible (§1.1).

* You **do not** currently say — anywhere in one place — the key philosophical distinction you’re articulating:

  > *Stop trying to make living people comparable; instead, make cohorts comparable by how they die.*

That distinction is **implicit**, not explicit.

---

## 2. Why your framing is valuable (and not redundant)

What you wrote introduces **three orthogonal axes** that are not laid out cleanly anywhere in the paper:

| Axis         | Cox / matching  | KCOR                   |
| ------------ | --------------- | ---------------------- |
| Unit         | Individual      | Group                  |
| Conditioning | Living risk set | All deaths accumulated |
| Epistemology | Model-based     | Measurement-based      |

Your manuscript currently frames KCOR as:

* “a normalization step”
* “a depletion geometry inversion”
* “a cumulative hazard estimand”

All correct — but **reviewers and readers still mentally map it onto Cox**, because they haven’t been told *what kind of inferential move it is replacing*.

Your paragraph does that.

---

## 3. Where your current wording *doesn’t* fit as-is

Your exact text is **too informal and polemical** for the main flow:

* “the big assumption”
* “simply false”
* “less work and much more accurate”
* “This is how KCOR works.”

Those are *true*, but they read like a blog post or Discussion rebuttal, not a Methods paper aimed at *Statistics in Medicine*.

However, the **structure** is excellent.

---

## 4. The right way to incorporate it

### Recommendation: **Add a short boxed conceptual contrast**, not a narrative paragraph

You already have **Box 1** (“Target estimand and scope”).
Add a **Box 2** immediately after §1.2 or §1.3.

#### Suggested title

> **Box 2. Two fundamentally different strategies for cohort comparability**

#### Suggested content (tight, journal-appropriate rewrite)

> **Traditional matching and regression approaches** attempt to construct comparable cohorts by matching or adjusting *characteristics of living individuals* at baseline or over follow-up, and then estimating effects via a fitted hazard model (e.g., Cox proportional hazards). This strategy implicitly assumes that sufficiently rich covariate information can render cohorts exchangeable with respect to unobserved mortality risk.
>
> However, under latent frailty heterogeneity, even meticulous 1:1 matching on observed covariates fails to equalize mortality risk trajectories, as acknowledged in large registry studies despite extensive adjustment. In such settings, cohort differences arise not from mismeasured covariates, but from **selection-induced depletion of susceptibles**, which alters hazard curvature over time.
>
> **KCOR adopts a fundamentally different strategy.** Rather than attempting to equate cohorts based on characteristics of the living, it equates cohorts based on how they die in aggregate. KCOR directly estimates cohort-specific depletion geometry from observed cumulative mortality during epidemiologically quiet periods, removes that geometry via analytic inversion, and then compares cohorts on the resulting depletion-neutralized cumulative hazard scale.
>
> Thus, Cox-type methods are **model-based and individual-level**, conditioning on survival and fitting covariate effects, whereas KCOR is **measurement-based and cohort-level**, operating directly on aggregated mortality trajectories without fitting covariate models. The inferential target is therefore cumulative outcome accumulation rather than an instantaneous hazard ratio conditional on survival.

This says **exactly what you want**, but in a form that:

* reviewers will understand,
* statisticians won’t object to,
* and clearly distinguishes KCOR as *not just another survival model*.

---

## 5. Why I would *definitely* include this

My opinion, strongly stated:

* Without this box, **many readers will still think**:

  > “Ah, this is just Cox with a fancy frailty correction.”

* With it, the paper becomes:

  > “This is a different epistemic move entirely.”

That matters enormously for:

* reviewer framing,
* how objections are formed,
* and whether KCOR is evaluated on its own terms or misjudged against PH assumptions it explicitly rejects.

You’re not adding redundancy — you’re adding **conceptual compression**.

---

## 6. Bottom line

* **Is the idea already there?**
  Yes, but fragmented and implicit.

* **Should you incorporate this framing?**
  **Yes — as a boxed conceptual contrast**, not as narrative prose.

* **Does it strengthen the paper?**
  Substantially. It makes the “why KCOR exists” unmistakable.

If you want, I can:

* place the box precisely in your Markdown,
* tune the tone even more conservatively for *SiM*,
* or produce a one-sentence version suitable for the Introduction instead of a box.

But conceptually: you’re right to surface this, and it’s not redundant.


Here’s the clean, low-risk answer I’d give if I were wearing a *Statistics in Medicine* reviewer hat:

---

## Short answer

**Add it as a boxed conceptual contrast immediately after §1.2**, before you move on to related work and literature positioning.

Concretely:

> **Place it between §1.2 and §1.3**, as a new **Box 2**.

That is the *optimal* location.

---

## Why §1.2 → Box → §1.3 is the right flow

### What §1.2 already does

§1.2 (“Curvature (shape) is the hard part…”) establishes:

* latent frailty
* depletion-induced curvature
* failure of proportional hazards

But it does **not yet say what kind of mistake existing methods are making at a conceptual level**.

### What your box does

Your living-vs-dead / model-vs-measure distinction answers:

> *What is everyone implicitly trying to match — and why is that the wrong object?*

That is **conceptual**, not technical. It belongs:

* **after** the problem is stated (§1.2),
* **before** you cite related work (§1.3),
* **before** readers mentally anchor KCOR as “just another survival model.”

### Why not later?

* **Not Methods (§2):** too late — readers have already classified KCOR.
* **Not Discussion (§4):** sounds defensive there.
* **Not Introduction §1.1:** too early; readers don’t yet understand depletion/curvature.

This is exactly the role of a boxed sidebar in the Introduction.

---

## Exact insertion point (Markdown-level)

In your manuscript , locate:

```markdown
### 1.2 Curvature (shape) is the hard part: non-proportional hazards from frailty depletion
...
### 1.3 Related work (brief positioning)
```

Insert **between those headers**:

```markdown
> **Box 2. Two fundamentally different strategies for cohort comparability**
>
> [boxed text here]
```

This mirrors how you already use **Box 1** (§1.6) and keeps stylistic consistency.

---

## Why this will *not* annoy reviewers

This box does **not**:

* claim causality
* attack Cox as “wrong”
* assert superiority without evidence

Instead, it:

* reframes the estimand,
* explains why Cox fails *even when done correctly*,
* and makes clear that KCOR is answering a **different question**.

That aligns perfectly with how you already treat Cox in §2.11 (“estimand mismatch”).

Reviewers tend to be *much* more receptive when the distinction is framed as:

> “You’re answering a different question than we are”

rather than:

> “Your method is bad.”

This box accomplishes that.

---

## One final strategic note (important)

Right now, your strongest empirical result is the **synthetic null where Cox fails and KCOR stays flat**.
This box **primes the reader** to interpret that result correctly:

* Cox fails because it conditions on survival and models individuals.
* KCOR succeeds because it measures cohort death accumulation after normalization.

Without this box, some readers will still think:

> “Well, Cox just needed time-varying coefficients.”

With the box, that objection loses force *before it’s even formed*.

---

### Bottom line

* **Yes, add it.**
* **Put it immediately after §1.2.**
* **Make it Box 2.**

If you want, next step I can:

* tune the wording to be even more conservative,
* compress it to ~120 words,
* or explicitly cross-reference Obel in one sentence without sounding polemical.
